Cancer Vaccine

Cancer Vaccine - most related articles:

- Gardasil vaccine to prevent cervical cancer in India - 5.1
- Brain cancer vaccine prepared from brain tumor proves effective - 4.7
- Many parents, high priority adults didn't get H1N1 vaccine - 4.3
- Universal Influenza vaccine holds promise - 4.3
- Universal influenza vaccine possible in future - 4.1
- Swine flu vaccine causing sudden sleep disorder narcolepsy in children - 4.1
- GSK's cervical cancer vaccine Cervarix got WHO prequalification - 4
- New bird flu vaccine may give long-term defense - 3.9
- Sanofi Pasteur's New Influenza Vaccine Plant, US - 3.9
- Swine flu vaccine trials under way, UK - 3.9

Cancer Vaccine articles

Brain cancer vaccine prepared from brain tumor proves effective
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme-which kills thousands of Americans every year.

HPV vaccine reduces subsequent cervical disease in women
HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.

Breast cancer vaccine reduces tumours in mice
Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.

Gardasil approved to prevent anal cancer
The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

New cancer research could lead to improved vaccines for cancerous tumors
Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.

Vaccine may cure chronic myeloid leukemia CML
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

GSK's cervical cancer vaccine Cervarix got WHO prequalification
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline's cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.

New gene silencing way to turn off cervical cancer genes
Researchers at The University of Queensland have developed a way to deliver drugs which can specifically shut down cancer-causing genes in tumour cells while sparing normal healthy tissues.

Diabetes drug metformin enhances cancer vaccine efficacy
University of Pennsylvania School of Medicine researchers have found that a common anti-diabetic drug might enhance the effectiveness of vaccines. The findings are described this week in an advanced online publication of Nature.

Benefit to women not enough to sway men to get HPV vaccine
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.

Gardasil is eligible for UN immunization programs
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.

Gardasil efficacious against HPV 16 infection
In a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.

Boosting immune response to destroy tumours
Researchers have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

Prostate cancer vaccine Provenge prolongs survival
Dendreon Corporation (Nasdaq: DNDN) announced that the pivotal Phase 3 IMPACT study of PROVENGE (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control.

Cervical cancer screening might safely be delayed after HPV vaccine
DNA from human papilloma virus type 16 (HPV16) and HPV type 18 (HPV18) were found in the majority of invasive cervical cancers in New Mexico in the 1980s and 1990s, according to a population-based study published in the March 24 online issue of the Journal of the National Cancer Institute.

Gardasil HPV vaccine prevented genital lesions in men
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

HPV vaccine Cervarix in UK's immunisation programme
The UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.

Gardasil HPV vaccine reduces abnormal pap test results
A significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

New strategies work to put cancer on the firing line
Dr. Yukai He wants to put cancer in the bull's eye. "Cancer really comes from us," the Medical College of Georgia Cancer Center immunologist says of the scary reality that cancer cells are our own cells gone awry. That means our immune system doesn't always see cancer as a horrific invader.

19 Cancer Vaccine articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
14.35